Document is current
Any future updates will be listed below
-
Authors
Czupryniak, Leszek
Dicker, Dror
Lehmann, Roger
Prázný, Martin
Schernthaner, Guntram http://orcid.org/0000-0003-2397-4468
-
Funding
Funding for this research was provided by:
Boeheringer Ingelheim RCV
- License Information
-
More Information
Article History
Received: 4 September 2021
Accepted: 20 September 2021
First Online: 1 October 2021
Declarations
:
: Not applicable.
: Not applicable.
: LC has served as a consultant for Abbott, Ascensia, Astra Zeneca, Bayer, Bioton, Boehringer Ingelheim, Eli Lilly, Medicover Foundation, Medtronic, Merck Serono, MSD, Mundipharma, Novo Nordisk, Roche and Sanofi and is on Speakers Bureaus for Abbott, Ascensia, Astra Zeneca, Bayer, Bioton, Boehringer Ingelheim, Eli Lilly, KRKA, Merck Serono, MSD, Novo Nordisk, Sanofi, and Servier, and received research funding from Bioton, Medicover Foundation, and TEVA Pharmaceuticals. DD has received speaker honoraria and consultancy fees from AstraZeneca, Boehringer Ingelheim, Novo Nordisk, Teva, and research grants from Boehringer Ingelheim, Novo Nordisk and Eli Lilly. RL has received honoraria from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Mundipharma, Merck Sharp & Dohme and Sanofi. MP has received speaker honoraria and has consulted for Abbott, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Merck Sharp & Dohme, Novartis, Novo Nordisk, Medtronic, Inc., Sanofi, Teva, and Roche. GS has received honoraria from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Mundipharma, Servier and Takeda for speaking at sponsored meetings or attending advisory boards.
